Cyclo Therapeutics Inc - Ordinary Shares - Class A

NASDAQ:CYTH   3:59:53 PM EDT
4.99
+0.19 (+3.96%)
Earnings Announcements

Cyclo Therapeutics Reports Qtrly Net Loss Per Common Share $0.60

Published: 11/15/2021 22:21 GMT
Cyclo Therapeutics Inc - Ordinary Shares - Class A (CYTH) - Cyclo Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results.
Cyclo Therapeutics - Qtrly Basic and Diluted Net Loss per Common Share $0.60.
Revenue is expected to be $0.39 Million
Adjusted EPS is expected to be -$0.36

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.